Rend Al-Mondhiry Quoted in “Is FDA Watching Heart Health Supplements in 2023?”
Nutritional Outlook spoke with ATW’s Rend Al-Mondhiry about ingredient trends in 2023.
Rend pointed to the trend they are seeing of FDA issuing groups of warning letters in conjunction with a press release, where FDA is sending a broad message to industry regarding these types of claims.
Rend noted that the line between structure-function claims and implied disease claims is especially blurry and not always apparent when a claim mentions cholesterol, blood pressure and even blood sugar. She emphasized that qualifying claims in these instances is key.
For the full story, click here.
